The drugs would still not be FDA-approved, and the FDA would still not vouch for their safety or effectiveness. Koehl Robinson, founder and CEO of CeliaRX, a telehealth company that sells injectable and topical peptides compounded by a 503A pharmacy partner (not the ones on the FDAs potential unbanned list), says that if the peptides are reclassified, it would likely open up new possibilities for her customers, as well as lead to more clarity and less confusion
Additionally, it normalizes circadian rhythms, reduces awakenings, and maintains rapid eye movement cycles without causing sedative effects or next-day drowsiness
AOD-9604 does not appear to affect insulin sensitivity or blood sugar, which is one of its key advantages over full-length hGH therapy
63 Overall, the authors suggested that potential non-TJal functions of claudin-7, including maintenance of epithelial cellmatrix interactions and intestinal homeostasis, may be responsible for the phenotype observed in claudin-7-null mice